CryoPort, Inc. Makes Initial Shipment for Quest Diagnostics

* Reuters is not responsible for the content in this press release.

Thu Apr 17, 2008 9:20am EDT 

  LAKE FOREST, CA, Apr 17 (MARKET WIRE) -- 
 CryoPort, Inc. (OTCBB: CYRX) today announced that it has made an initial
shipment of clinical samples on behalf of Quest Diagnostics.

    This shipment was comprised of clinical samples that were shipped
internationally.  Federal Express handled all shipping segments.

    Peter Berry, CEO of CryoPort, commented,  "The CryoPort Express(TM)
Shipperperformed perfectly keeping the samples frozen and safe. We anticipate
handling
other shipments for diagnostic laboratories as we build out our logistics
platform both in the US and Europe."

    Peter Berry continued, "With every shipment we are learning and building our
platform to serve the needs of our clients. While this process is continuing
we are working very diligently at adding new potential customers to our roster
of
initial users."

    To be added to the CryoPort Investor email list, please email
edward@carpedminc.com with CYRX in the subject line.

    About CryoPort, Inc.

    CryoPort (www.cryoport.com) develops leading edge, proprietary,
technology-driven
shipping and storage products for use in the rapidly growing global
biotechnology
and biopharmaceutical cold chain. The products developed by CryoPort are
essential
components of the infrastructure required for the testing, research and end user
delivery of temperature-sensitive medicines and biomaterials in an
increasingly complex logistical environment.

    "SAFE HARBOR"

    This press release contains forward-looking statements. The words
"estimate,"
"possible" and "seeking" and similar expressions identify forward-looking
statements, which speak only as to the date the statement was made. The company
undertakes no obligation to publicly update or revise any forward-looking
statements, whether because of new information, future events, or otherwise.
Forward-looking statements are inherently subject to risks and
uncertainties, some of which cannot be predicted, or quantified. Future events
and
actual results could differ materially from those set forth in, contemplated
by, or underlying the forward-looking statements. The risks and uncertainties to
which forward-looking statements are subject include, but are not limited to,
the
effect of government regulation, competition and other material risks.

    

Contact:
Stuart Fine
Carpe DM, Inc.
908-469-1788
stuart@carpedminc.com

Copyright 2008, Market Wire, All rights reserved.

-0-
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.